Topics

Diffuse midline glioma | Overall management | H3K27M˄BRAFV600E-altered

Home > Publications > Topics > Diffuse midline glioma > Overall management > H3K27M˄BRAFV600E-altered

Chen CG, Rameh V, Rosenberg T, Yeo KK, Chi S, Wright KD, Baird LC, Filbin MG, Fehnel KP, Abdullaev Z, Aldape KD, Lidov HG, Alexandrescu S.
H3K27M- and BRAF V600E-Altered gliomas and glioneuronal tumors-clinico-pathologic and radiologic perspective in a cohort treated with targeted therapy.
Neurooncol Adv. 2025 Sep 8;7(1):vdaf197. doi: 10.1093/noajnl/vdaf197. PMID: 41473746. Observational study. ˍ